Literature DB >> 12407018

Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells.

Takeo Usui1, Toshiyuki Murai, Toshiyuki Tanaka, Kazuhito Yamaguchi, Daisuke Nagakubo, Chun Man Lee, Masaaki Kiyomi, Shinji Tamura, Yuji Matsuzawa, Masayuki Miyasaka.   

Abstract

Previous results have indicated that mac25/angiomodulin (AGM) is expressed in lymph node (LN) high endothelial venules (HEV), the specialized venules that support efficient lymphocyte transendothelial migration. How mac25/AGM's endothelial expression pattern is regulated in situ remains unknown. Here, we demonstrate that in mouse LN blood vessels, including HEV, mac25/AGM is localized, unlike previous reports, not to the luminal or lateral regions bordering the endothelial cells (EC), but exclusively to the basal lamina that is in direct association with EC. In the spleen, mac25/AGM was expressed in the vascular basal lamina, in direct association with smooth muscle cells and pericytes, but not with EC. In addition, we report herein that mac25/AGM is an inducible marker for activated EC. In inflamed tissues, mac25/AGM expression was strongly induced in the abluminal region of blood vessels. In vitro, mac25/AGM was readily induced in EC upon activation with pro-inflammatory cytokines such as tumor necrosis factor-alpha, indicating that mac25/AGM is an activated EC marker. mac25/AGM binds vascular endothelial growth factor and, together with its strict abluminal localization, it is suggested that mac25/AGM has a specific function(s) in the subendothelium of activated blood vessels such as capturing humoral factors produced in the vicinity of HEV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407018     DOI: 10.1093/intimm/dxf102

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression.

Authors:  Rong-Yi Chen; Hong-Xiang Chen; Jia-Xi Lin; Wei-Bing She; Ping Jiang; Li Xu; Ya-Ting Tu
Journal:  J Exp Clin Cancer Res       Date:  2010-02-16

2.  Human Adipose Stem Cells (hASCs) Grown on Biodegradable Microcarriers in Serum- and Xeno-Free Medium Preserve Their Undifferentiated Status.

Authors:  Francesco Muoio; Stefano Panella; Valentin Jossen; Matias Lindner; Yves Harder; Michele Müller; Regine Eibl; Tiziano Tallone
Journal:  J Funct Biomater       Date:  2021-04-16

3.  Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis.

Authors:  Andrea T Hooper; Sergey V Shmelkov; Sunny Gupta; Till Milde; Kathryn Bambino; Kelly Gillen; Mollie Goetz; Sai Chavala; Muhamed Baljevic; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; Gavin Thurston; George D Yancopoulos; Linda Vahdat; Todd Evans; Shahin Rafii
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

4.  Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients.

Authors:  Håvard Loftheim; Karsten Midtvedt; Anders Hartmann; Anna V Reisæter; Pål Falck; Hallvard Holdaas; Trond Jenssen; Leon Reubsaet; Anders Asberg
Journal:  Transplant Res       Date:  2012-08-31

5.  Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3.

Authors:  Eriko Komiya; Hiroki Sato; Naoko Watanabe; Marii Ise; Shouichi Higashi; Yohei Miyagi; Kaoru Miyazaki
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452

6.  Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics.

Authors:  Abdulla Ahmed; Salaheldin Ahmed; Mattias Arvidsson; Habib Bouzina; Jakob Lundgren; Göran Rådegran
Journal:  ESC Heart Fail       Date:  2020-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.